Regulators in Utah have given the green light to a new service that lets users obtain acne medication through an artificial-intelligence platform. The approval enables the startup Nolla Health to operate a system that evaluates facial images and issues prescriptions without a traditional in-person visit, marking a notable shift in how dermatologic care can be delivered.
Customers download the Nolla Health app, capture a clear picture of their face, and allow the embedded AI to assess the severity of their acne. Based on this analysis, the algorithm selects an appropriate treatment and generates a prescription automatically, streamlining the process that normally requires a clinician’s manual assessment and paperwork.
The rollout follows a staged oversight model. For the first hundred users, two licensed physicians must sign off on each AI-generated prescription before it is sent to the patient. After the program reaches a threshold of five hundred prescriptions, physician involvement shifts to a sampling approach, with at least ten percent of prescriptions reviewed each month along with any cases that involve complications or escalations.
The service is priced at $4.99 per month and is limited to Utah residents who are eighteen years of age or older and who present with mild-to-moderate acne. The subscription model covers the AI analysis, prescription generation, and ongoing monitoring, while also providing a pathway to a human doctor if the algorithm cannot determine a suitable treatment with confidence.
Nolla Health’s AI currently supports eight distinct acne therapies, ranging from topical agents to oral medications. When the system encounters an image it cannot evaluate reliably, it directs the user to a qualified physician for further assessment, ensuring that patients receive appropriate care even in edge cases where the algorithm’s certainty is low.
The initiative was first reported by Bloomberg and represents one of the earliest examples of a state-level endorsement for fully automated prescription issuance. Observers note that the pilot could serve as a template for other jurisdictions seeking to balance innovative digital health solutions with patient safety safeguards.